Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-066984
Filing Date
2025-07-23
Accepted
2025-07-23 16:15:56
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0249294-10q_180life.htm   iXBRL 10-Q 1036209
2 CERTIFICATION ea024929401ex31-1_180life.htm EX-31.1 9989
3 CERTIFICATION ea024929401ex31-2_180life.htm EX-31.2 9687
4 CERTIFICATION ea024929401ex32-1_180life.htm EX-32.1 3209
5 CERTIFICATION ea024929401ex32-2_180life.htm EX-32.2 3290
6 GRAPHIC image_001.jpg GRAPHIC 17023
  Complete submission text file 0001213900-25-066984.txt   6251692

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20250630.xsd EX-101.SCH 60448
8 XBRL CALCULATION FILE atnf-20250630_cal.xml EX-101.CAL 32098
9 XBRL DEFINITION FILE atnf-20250630_def.xml EX-101.DEF 310338
10 XBRL LABEL FILE atnf-20250630_lab.xml EX-101.LAB 526889
11 XBRL PRESENTATION FILE atnf-20250630_pre.xml EX-101.PRE 315231
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0249294-10q_180life_htm.xml XML 621659
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 251143306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)